---
category: news
title: "Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery"
excerpt: "Jul. 26, 2021– Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent,"
publishedDateTime: 2021-07-26T15:26:00Z
originalUrl: "https://synbiobeta.com/twist-bioscience-incorporates-molcure-ai-technology-to-augment-therapeutic-antibody-discovery/"
webUrl: "https://synbiobeta.com/twist-bioscience-incorporates-molcure-ai-technology-to-augment-therapeutic-antibody-discovery/"
type: article
quality: 28
heat: 28
published: false

provider:
  name: SynBioBeta
  domain: synbiobeta.com

topics:
  - AI Hardware
  - AI

images:
  - url: "https://synbiobeta.com/wp-content/uploads/2021/03/dna-163466_1280.jpg"
    width: 1280
    height: 720
    isCached: true

secured: "gipvRsExyztzD2S157TTneD1iiRk5zlv0zs7sSLwn03pj9A/gORg05yYQ2Dvwv47nu8ADjC/h6wf94NyQWjQNJoMTzR/Z2LID7J77hXmHHET6zb4MKXcBIoSfHpgB1Uv5zftpfSpLobgRdE1qlM3AOC8kSZvVkzmEo0RPYU03L31Mv1YyTpRQLhvbSW3Oe+Gu1ni8NBevCQQPNgJo+ciKVGnXymk5yw8hyqQaEkxjKdV4ImcGUfWy7PNPUSQUYvi7AyllfS3n9WKLpZOQ0bBtF/P5sUe4GEb83tDjzbPn9WTDZWoqbXm6FtnL+nfTDC00c6NE5wtiNYxMNzWHwG/knI9+Vy0NBhVgdmA0zWWFgo=;Hum1gqC+T7CTpaS6cZEI+Q=="
---

